SEARCH:

Conference call (Acquisition of vaccines from GSK)

October 21, 2019 | Investor

Following the announcement of the acquisition of Rabipur®/RabAvert® and Encepur® from GlaxoSmithKline, the management of Bavarian Nordic held a conference discuss the acquisition.

A replay version of the presentation can be accessed via the link below.